Skip to main content

Table 2 Odds of response after neoadjuvant chemotherapy from logistic regression model. N = 50

From: Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer

Characteristic

OR (95 % CI)

P

Univariate

 Age

5.6 (1.6–20.0)

0.008

 sTIL

0.46 (0.29–0.72)

0.001

 Stroma

6.6 (1.9–23.4)

0.003

 colXα1

18.9 (2.8–129)

0.003

Multivariate

 Age

0.23 (0.009–5.9)

0.37

 sTIL

0.39 (0.16–0.92)

0.03

 Stroma

1.9 (0.17–22)

0.6

 colXα1

28 (1.6–487)

0.022

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us